Please try another search
As of May 17, 2023, Selectimmune Pharma AB (publ) was acquired by Hamlet BioPharma AB (publ). Selectimmune Pharma AB (publ), a pharmaceutical company, develops drugs for the treatment of acute and chronic infections. The company products include IL-1 receptor antagonists, as well as NK1R, RNA Pol II, and IRF7 inhibitors. It has a collaboration agreement with Lonza to develop processes for NlpD, an immunotherapy protein. The company was incorporated in 2017 and is based in Lund, Sweden.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review